期刊文献+

食管鳞癌患者CRP测定的临床价值 被引量:1

The Clinical Value of Serum CRP in Patients with Esophageal Squamous Cell Carcinoma
下载PDF
导出
摘要 目的探讨血清C反应蛋白(C-reactive protein,CRP)在测定食管鳞癌患者诊治中的临床价值。方法测定138例食管鳞癌患者血清CRP水平,并与健康对照组进行比较。分析食管鳞癌患者术前CRP水平与临床病理特征的关系及手术前后CRP水平变化及与并发症的关系。结果食管鳞癌组术前CRP水平显著高于健康对照组,并随TNM分期的进展而升高,淋巴结转移阳性者术前CRP显著高于淋巴结转移阴性者,术前CRP水平与年龄、性别、肿瘤部位、术后有无并发症无关。无并发症组术后2周CRP水平逐渐降低接近正常,有并发症组术后2周CRP仍显著升高。结论 CRP检测方便,灵敏度高,可作为食管鳞癌患者辅助诊断、治疗及预后评价的指标。 Objective To explore the value of C-reactive protein(CRP) in the diagnosis and treatment of patients with esophageal squamous cell carcinoma. Methods The levels of CRP in 138 cases of patients with respectable esophageal squamous cell carcinoma and healthy controls were tested before and after operation. The relationship between the level of CRP and the clinical and pathological parameters were analyzed. Results The CRP level in patients with esophageal squamous cell carcinoma was higher than that of healthy controls. The serum CRP levels in patients with esophageal squamous cell carcinoma were significantly related with advanced tumor TNM stage (P =0. 001 ), lymph node status (P = 0. 001 ), but not related with patients'age, sex, tumor location and complications. The serum CRP levels in patients with no complications were decreased dramatically 2 weeks after the treatment of surgery and nearly to normal; however the level of the patients with serious postoperative complications was still higher than that of healthy controls. Conclusion The serum CRP is a reliable and sensitive index for the auxiliary diagnosis and treatment of patients with esophageal squamous cell carcinoma.
出处 《标记免疫分析与临床》 CAS 2015年第7期637-639,共3页 Labeled Immunoassays and Clinical Medicine
关键词 食管鳞癌 手术治疗 C反应蛋白 Esophageal squamous cell Carcinoma Surgical Treatment C-reactive protein
  • 相关文献

参考文献10

  • 1Wang C S, Sun C F. C-reactive protein and malignancy: clinico- pathological association and therapeutic implication. Chang Gung Med J, 2009,32(5) :471-482.
  • 2Ferlay J, Shin H R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010; 127 (12) : 2893-2917.
  • 3Chen W,Zheng R, Zhang S, et al. Report of cancer incidence and mortality in China, 2010. Ann Transl Med, 2014,2(7) :61-85.
  • 4张思维,雷正龙,李光琳,邹小农,赵平,陈万青.中国肿瘤登记地区2006年肿瘤发病和死亡资料分析[J].中国肿瘤,2010,19(6):356-365. 被引量:192
  • 5Chaturvedi A K, Caporaso NE, Katki H A,et al, C-reactive protein and risk of lung cancer. J Clin Oncol,2010,28(16) :2719-2726.
  • 6Erlinger T P, Platz E A, Rifai N, et al, C-reactive protein and the risk of incident colorectal cancer. JAMA. 2004,291 (5) :585-590.
  • 7Shacter E, Weitzman S A. Chronic inflammation and cancer. Oncology ( Williston Park) , 2002, 16 ( 2 ) : 217-232.
  • 8McMillan D C,Elahi M M, Sattar N, et al. Measurement of the systemic inflammatory response predicts cancer-specific and non- cancer survival in patients with cancer. Nutr Cancer, 2001, 41 ( 1 - 2) : 64-69.
  • 9张琳,吴兴平,丁伟龙,杨娟,刘万里.Cyfra21-1和CEA及CRP联合检测对食管癌诊断价值的探讨[J].中华肿瘤防治杂志,2012,19(9):667-670. 被引量:20
  • 10Dutta S, Fullarton G M, Forshaw M J, et al. Persistent Elevation of C- Reactive Protein Following Esophagogastric Cancer Resection as a Predictor of Postoperative Surgical Site Infectious Complications, World J Surg,2011, 35(5) :1017-1025.

二级参考文献31

  • 1张思维,雷正龙,李光琳,邹小农,陈万青,赵平.中国肿瘤登记地区2005年发病死亡资料分析[J].中国肿瘤,2009,18(12):973-979. 被引量:32
  • 2吴健民.对肿瘤标志物的再认识[J].中华检验医学杂志,2005,28(1):11-13. 被引量:116
  • 3Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I : comparability, validity and timeliness [J]. Eur J Cancer, 2009, 45: 747-755.
  • 4Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, Vol. IX. IARC scientific: publications No. 160[M], Lyon: IARC, 2007.
  • 5Parkin DM, Chen VM, Ferlay J, et al. Comparability and quality control in cancer registration. IARC technical report No.19[M]. Lyon: IARC, 1994.
  • 6Felay J, Bnrkhard C, Whelan S, et al. Check and conversion programs for cancerregistries. IARC Technical Report No. 42[M]. Lyon: IARC, 2005.
  • 7Felay J. The IARCcrgTools program [EB/OL]. http://www.iacr.com.fr/iarccrgtools.htm, 2006.
  • 8赵平,陈万青.2008年中国肿瘤登记年报[M].第1版.北京:军事医学科学出版社,2009.88-89.
  • 9Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics,2002 [J]. CA CancerJ Clin,2005,55(2):74 108.
  • 10Tew WP,Kelsen DP, Ilson DH. Targeted therapies for esopha- geal cancer [J]. Oncologist, 2005,10(8) : 59-60.35 39.

共引文献210

同被引文献11

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部